Quick Answer
RECURSION PHARMACEUTICALS, INC. reported Total Revenue of $74.68 million for fiscal year 2025.
RECURSION PHARMACEUTICALS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $74.68M | +26.9% |
| 2024 | $58.84M | +32.0% |
| 2023 | $44.58M | +11.9% |
| 2022 | $39.84M | +291.5% |
| 2021 | $10.18M | +156.9% |
| 2020 | $3.96M | +70.8% |
| 2019 | $2.32M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.17M | -80.2% | -73.1% |
| June 30, 2025 | $19.22M | +33.3% | +30.4% |
| March 31, 2025 | $14.74M | +6.9% | -43.5% |
| September 30, 2024 | $26.08M | +147.6% | +80.9% |
| June 30, 2024 | $14.42M | +30.9% | +4.5% |
| March 31, 2024 | $13.79M | +13.7% | +31.0% |
| September 30, 2023 | $10.53M | -20.0% | -4.4% |
| June 30, 2023 | $11.02M | +43.6% | -9.2% |
- RECURSION PHARMACEUTICALS, INC. showed an increase of +26.9% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, RECURSION PHARMACEUTICALS, INC.’s total revenue has grown by 3120.4% (from $2.32 million to $74.68 million).
- The most recent figure is from RECURSION PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: